ProCertus BioPharm
ProCertus BioPharm, founded in 1997 and based in Madison, Wisconsin, is a private biotechnology company developing therapeutics to protect cancer patients from radiotherapy and chemotherapy side effects. The firm operates with a lean team of 1-10 employees.
- Company typePrivate
- Founded2024
- HeadquartersMadison, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What ProCertus BioPharm does
ProCertus BioPharm is a privately held, development-stage biotechnology company founded in 1997 and headquartered in Madison, Wisconsin. According to firmographic records, the company develops therapeutics intended to protect cancer patients from the adverse side effects of radiotherapy and chemotherapy, operating in the radioprotection and chemoprotection niche adjacent to supportive oncology. The company runs with a footprint of 1-10 employees, consistent with a focused, capital-efficient R&D operation rather than a commercial-stage organization.
The company has raised approximately $6.17 million across four recorded financing events between 2007 and 2011, with Novartis Venture Fund and Clarevia Ventures identified as the principal institutional backers (Novartis Venture Fund participating across multiple rounds, Clarevia leading the 2007 round). Paul Weiss is named as Acting President & CEO, a designation consistent with an interim or underbuilt executive bench. No lead product candidate, mechanism of action, clinical trial status, intellectual property portfolio, partnership economics, or commercialization pathway is represented in the available input data.
Revenue mechanics for a therapeutics developer at this footprint typically derive from equity financing, potential non-dilutive grant income, and forward licensing milestones rather than product sales; the input does not include pricing, contracts, or licensing terms that would substantiate commercial revenue. Data within the input dates back to 2011, and the firmographic snapshot reflects a small R&D-stage posture without evidence of subsequent clinical, commercial, or financing events, which materially constrains forward-looking visibility.
ProCertus BioPharm firmographics
Firmographics- Name
- ProCertus BioPharm
- Legal name
- PROCERTUS asbl
- Website
- https://procertus.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ProCertus BioPharm, founded in 1997 and based in Madison, Wisconsin, is a private biotechnology company developing therapeutics to protect cancer patients from radiotherapy and chemotherapy side effects. The firm operates with a lean team of 1-10 employees.
- Ownership category
- akta.pro rank
ProCertus BioPharm industry classification
Industry- Product category
- Construction Materials Certification
- NAICS
- Cement and Concrete Product Manufacturing (3273), Other Concrete Product Manufacturing (327390)
- SIC
- Concrete, Gypsum & Plaster Products (3270), Concrete Products, Except Block & Brick (3272)
- akta.pro primary industry
- Ready-Mix Concrete Production & Delivery (IMADAAAA)
- akta.pro secondary industry
- Precast Concrete Products (IMADAAAB)
Keywords
Where ProCertus BioPharm is headquartered
LocationHeadquarters
- HQ city
- Madison
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ProCertus BioPharm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Others
Revenue model
- Certification Services: PROCERTUS generates revenue through certification fees for materials, concrete, mortar, and steel products in the Belgian construction industry. Services include certification, inspection, attestation of innovation, metrology, and interlaboratory comparison programs.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
ProCertus BioPharm product offering
Product offeringCore offering
PROCERTUS is an independent certification body providing third-party certification, inspection, metrology, standardization, and interlaboratory comparison services for the Belgian concrete and construction steel industry. Services are organized across three certification clusters — Materials (cement, aggregates, additives, lime), Concrete & Mortar (ready-mix, precast, mortar), and Steel (reinforced/prestressed steel, construction steel, structures) — and include innovation attestation for new products.
Product overview
PROCERTUS is a unified certification organization formed in April 2024 through the merger of BE-CERT, PROBETON, and OCAB-OCBS. It provides certification, inspection, and metrology services for Belgium's concrete and steel construction industry. The organization's offerings are organized into three main certification clusters—Materials (cement, aggregates, additives, lime), Concrete & Mortar (ready-mix, prefabricated, mortar), and Steel (reinforced/pre-stressed steel, construction steel, structures)—supported by standardization services, interlaboratory comparison programs, metrology services, and innovation attestation. Customers access certificates and documents through dedicated extranet portals organized by cluster.
Differentiator
Problem solved
Functional benefit
Products and services
- Certification & Inspection Independent third-party certification and inspection services for cement, aggregates, additives, ready-mix concrete, precast concrete, mortar, and steel/aluminum structures used in Belgian construction projects. Issued under BENOR and ATG marks.
- Metrology Services Metrology service that verifies and calibrates measuring equipment for laboratories and industry clients in the construction sector, focused on accuracy and precision.
- Standardization (Normalisation) Standardization services supporting industry norms and regulatory compliance for the Belgian concrete and construction steel sector.
- Innovation Attestation Attestation service for certifying innovative construction products or processes against Belgian technical approval requirements.
- Interlaboratory Comparison Programs Proficiency testing programs that compare measurement results across laboratories for cement, fly ash, and lime, supporting lab quality assurance in the construction materials sector.
Companies that use ProCertus BioPharm
Customer profileSegments3 records
Ideal customer profiles4 records
ProCertus BioPharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
ProCertus BioPharm partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- BENORcoreBENOR is the Belgian certification mark for construction products. PROCERTUS operates as a BENOR certification body, providing certification services for construction materials that meet Belgian quality standards and regulatory requirements.
- ATG (UBaTC)coreATG (Technische Goedkeuring - Technical Approval) is managed by UBaTC (Union Belge pour l'Agrément technique de la Construction). PROCERTUS provides ATG certification services, which are technical approvals for innovative construction products in Belgium.
- BE-CERT, PROBETON, OCAB-OCBSflagshipPROCERTUS was formed in April 2024 through the merger of three Belgian certification organizations: BE-CERT, PROBETON, and OCAB-OCBS. This merger combined their knowledge and expertise in the concrete and construction steel industry into a single independent reference point.
Scale indicators3 records
Recent moves5 records
Expansion highlights3 records
ProCertus BioPharm competitors and assessment
Company assessmentBroad incumbents
- DNV: Norwegian-headquartered global TIC firm with a growing construction and infrastructure assurance practice. Comparable as a broad incumbent offering scheme-based certification and inspection services that overlap with PROCERTUS's portfolio.
- TÜV Rheinland: German-headquartered global TIC organization offering construction materials testing and certification. Comparable as a broad incumbent operating scheme-based certification for building materials in multiple European markets.
- SGS: World's largest TIC company, providing construction materials testing, inspection, and certification globally. Comparable as a broad incumbent whose construction vertical overlaps with PROCERTUS's certification and inspection services.
- Bureau Veritas: Global TIC major offering construction materials testing and certification services across multiple geographies. Relevant comparable because it competes with PROCERTUS for large construction manufacturer accounts and operates adjacent certification and inspection service lines.
- Apave: French TIC firm specializing in construction, infrastructure, and industrial risk management, including construction materials testing and inspection. Comparable to PROCERTUS in scope of construction-focused certification and inspection services.
Others
- BENOR: Belgian certification mark owner for construction products. PROCERTUS operates as an accredited BENOR certification body, so BENOR is a scheme-owner / ecosystem partner rather than a direct competitor, but materially shapes PROCERTUS's addressable market.
- UBAtC: Belgian Union for Technical Approval in Construction, manager of the ATG technical approval scheme. PROCERTUS issues ATG certifications, making UBaTC an adjacent scheme-owner and ecosystem participant rather than a peer competitor.
Direct peers
- KIWA: Dutch TIC (testing, inspection, certification) organization with a strong construction materials and steel certification portfolio across the Benelux. Closest comparable to PROCERTUS in terms of serving Northern European construction material producers with scheme-based certification and inspection services.
- CERIB: French technical center and certification body for the concrete industry, providing certification, testing, and standardization for concrete products. Comparable to PROCERTUS's Concrete & Mortar cluster (ready-mix, precast, mortar) and Materials cluster (cement, aggregates).
- AFCAB: French certification body specifically for reinforcing and prestressing steels used in concrete. Highly comparable to PROCERTUS's Steel cluster, which certifies reinforced and prestressed steel for the Belgian market — same product category, adjacent geography.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
ProCertus BioPharm social profiles
Digital presenceProCertus BioPharm compliance and trust
Trust signalCompliance2 records
ProCertus BioPharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProCertus BioPharm leadership team
Management profileNumber of profiles
ProCertus BioPharm funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProCertus BioPharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProCertus BioPharm
What does ProCertus BioPharm do?
PROCERTUS is an independent certification body providing third-party certification, inspection, metrology, standardization, and interlaboratory comparison services for the Belgian concrete and construction steel industry. Services are organized across three certification clusters — Materials (cement, aggregates, additives, lime), Concrete & Mortar (ready-mix, precast, mortar), and Steel (reinforced/prestressed steel, construction steel, structures) — and include innovation attestation for new products.
Is ProCertus BioPharm a public or private company?
ProCertus BioPharm is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was ProCertus BioPharm founded?
ProCertus BioPharm was founded in 2024. It employs 1 to 10 people.
Where is ProCertus BioPharm based?
ProCertus BioPharm is headquartered in Madison, United States, in the North America region.
How does ProCertus BioPharm make money?
One revenue line is on record: certification Services.
Who are ProCertus BioPharm's main competitors?
Broad incumbents on record are DNV, TÜV Rheinland, SGS, Bureau Veritas and Apave. Others are BENOR and UBAtC. Direct peers are KIWA, CERIB and AFCAB.
Does ProCertus BioPharm have an API?
No public API is recorded for ProCertus BioPharm.
What industry is ProCertus BioPharm in?
ProCertus BioPharm's product category is Construction Materials Certification. Its primary akta.pro industry code is IMADAAAA, Ready-Mix Concrete Production & Delivery, with a secondary code of IMADAAAB, Precast Concrete Products. Its NAICS code is 3273 and its SIC code is 3270.